Unexplained weight loss (UWL), defined as a decrease of 5% or more in body weight over a period of 6-12 months without a known cause, is a challenging clinical scenario. It can be indicative of a myriad of underlying conditions, ranging from malignancies to chronic infections, and therefore demands a comprehensive, systematic approach.
The first step in the assessment of UWL is a thorough history and physical examination. Special attention should be given to dietary intake, physical activity, psychological status, and medication use. The presence of symptoms like fever, pain, or changes in bowel habits might suggest specific etiologies.
Basic laboratory investigations, including complete blood count, renal and liver function tests, thyroid function tests, and markers of inflammation, are usually conducted in all patients. Imaging studies, such as chest X-ray or abdominal ultrasound, may be considered based on the patient's symptoms and risk factors. More targeted investigations, like endoscopy or biopsy, may be needed if initial tests are inconclusive.
Management strategies for UWL depend on the underlying cause. In some cases, symptom management and nutritional support may be all that's required. In others, specific treatments for identified diseases are necessary. It's crucial to involve a multidisciplinary team, including dietitians and psychologists, in the patient's care.
The approach to UWL in clinical practice requires careful evaluation, a high index of suspicion, and a patient-centered approach. By combining a thorough history, physical examination, and appropriate investigations, clinicians can effectively diagnose and manage the underlying causes of UWL. Continued research is needed to improve our understanding and management of this complex clinical scenario.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation